TW201705989A - 注射劑 - Google Patents

注射劑 Download PDF

Info

Publication number
TW201705989A
TW201705989A TW105120167A TW105120167A TW201705989A TW 201705989 A TW201705989 A TW 201705989A TW 105120167 A TW105120167 A TW 105120167A TW 105120167 A TW105120167 A TW 105120167A TW 201705989 A TW201705989 A TW 201705989A
Authority
TW
Taiwan
Prior art keywords
injection
solvent
water
dimethyl hydrazine
gellan gum
Prior art date
Application number
TW105120167A
Other languages
English (en)
Chinese (zh)
Inventor
宮崎達也
岡部高明
眞崎賢治
山田和人
Original Assignee
參天製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 參天製藥股份有限公司 filed Critical 參天製藥股份有限公司
Publication of TW201705989A publication Critical patent/TW201705989A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW105120167A 2015-06-25 2016-06-27 注射劑 TW201705989A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015127600 2015-06-25

Publications (1)

Publication Number Publication Date
TW201705989A true TW201705989A (zh) 2017-02-16

Family

ID=57585212

Family Applications (1)

Application Number Title Priority Date Filing Date
TW105120167A TW201705989A (zh) 2015-06-25 2016-06-27 注射劑

Country Status (3)

Country Link
JP (1) JP2017008047A (ja)
TW (1) TW201705989A (ja)
WO (1) WO2016208742A1 (ja)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3088137B2 (ja) * 1990-07-18 2000-09-18 エーザイ株式会社 １，４−ジヒドロナフトキノン誘導体およびその製造方法
JP2004196787A (ja) * 2002-12-04 2004-07-15 Santen Pharmaceut Co Ltd 結膜下デポによるドラッグデリバリーシステム
JP4344153B2 (ja) * 2003-03-07 2009-10-14 浜松ホトニクス株式会社 微粒子の製造方法及び製造装置、並びに注射剤の製造方法
EP2508170B1 (en) * 2009-12-03 2015-07-29 Jiangsu Hengrui Medicine Co., Ltd. Liposome of irinotecan or its hydrochloride and preparation method thereof
ES2391721T3 (es) * 2010-03-01 2012-11-29 Laboratorios Salvat, S.A. Disoluciones acuosas transparentes de acetónido de fluocinolona para el tratamiento de la infamación de oído
JP2013103899A (ja) * 2011-11-11 2013-05-30 Fuji Chem Ind Co Ltd 難溶性薬物の新規な固体分散体
ES2608857T3 (es) * 2012-12-18 2017-04-17 Salipro Biotech Ag Partículas Salipro
SG11201602020QA (en) * 2013-09-20 2016-04-28 Santen Pharmaceutical Co Ltd Polyethylene glycol-containing composition

Also Published As

Publication number Publication date
JP2017008047A (ja) 2017-01-12
WO2016208742A1 (ja) 2016-12-29

Similar Documents

Publication Publication Date Title
CN110664757B (zh) 纳米晶滴眼剂、其制备方法及其应用
WO2004050060A1 (ja) 結膜下デポによるドラッグデリバリーシステム
TWI773641B (zh) 含有糖皮質類固醇（ｇｌｕｃｏｃｏｒｔｉｃｏｉｄｓ）之奈米微粒子之水性懸浮液劑
CA3036474A1 (en) Therapeutic agent for an ophthalmic disease comprising a vegf receptor inhibitor
EP3685828B1 (en) Ophthalmic pharmaceutical composition, ophthalmic kit, and pharmaceutical application thereof
JP2013501579A5 (ja)
WO2015099029A1 (ja) 注射剤およびデポ形成方法
CN102085203B (zh) 左氧氟沙星和醋酸泼尼松龙的眼用制剂及其制备方法
CN104168901A (zh) 后发性白内障抑制用组合物及其制备方法
JP6931257B2 (ja) レバミピドを含有する新規ドライアイ治療用点眼組成物及びその可溶化及び安定化方法
CN105106107A (zh) 一种苄达赖氨酸眼用结冷胶原位凝胶剂及其制备方法
CN111249442B (zh) 一种脂质纳米囊滴眼剂及其制备方法
TW201705989A (zh) 注射劑
JP6522592B2 (ja) １ｈ−インドール−１−カルボキサミド誘導体を含有する局所水性眼科用組成物および眼疾患の治療へのその使用
JP2023503081A (ja) 眼疾患の予防または治療用点眼組成物
JP2019534269A5 (ja)
JP2006257080A (ja) ステロイド化合物の副作用軽減または回避方法
CN110200904A (zh) 一种降眼压缓释滴眼组合物及其制备方法
CN111358751B (zh) 眼用药物组合物、眼用药盒及其医药用途
CN106310285A (zh) 一种新的盐酸利舒地尔滴眼液及其制备方法
CN111358750B (zh) 一种眼用药物组合物及其医药用途
CN103251592B (zh) 轴突形成促进剂
JP3504656B2 (ja) 水性医薬組成物
JP2002037746A (ja) キノロンカルボン酸系抗菌剤を含有する液剤
JP2024512028A (ja) Ｎ－オキソピリジン化合物の発生を抑制する眼疾患の予防または治療用点眼組成物